Keeping Order in the Neighborhood: New Roles for TGFβ in Maintaining Epithelial Homeostasis  by Wakefield, Lalage M. & Stuelten, Christina
Cancer Cell
PreviewsKeeping Order in the Neighborhood: New Roles 
for TGFβ in Maintaining Epithelial Homeostasis
Lalage M. Wakefield1,* and Christina Stuelten2
1Lab of Cancer Biology and Genetics
2Cell and Cancer Biology Branch
Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA
*Correspondence: lw34g@nih.gov
DOI 10.1016/j.ccr.2007.10.002
TGFβs are thought to have tumor suppressor activity in many organ systems, but receptor inactiva-
tion in mouse models has not previously resulted in increased spontaneous tumorigenesis. A study 
in this issue of Cancer Cell shows that mice with a targeted knockout of the type II TGFβ receptor 
in stratified epithelia specifically develop spontaneous squamous cell carcinomas in the anogenital 
region, but not in the skin. Loss of TGFβ signaling appears to destabilize the epithelium such that 
homeostasis fails in the face of persistent proliferative challenge, a normal feature of the anogenital 
site, and latent invasive and migratory phenotypes are unmasked.The TGFβs are remarkably pleiotro-
pic molecules, evoking a wide range 
of biological responses from cells in 
all major lineages of the body. Within 
this repertoire of activities, their abil-
ity to potently inhibit the prolifera-
tion of epithelial cells is particularly 
striking. Since the TGFβs are widely 
expressed, and many human cancers 
show aberrations in TGFβ receptor 
expression or function, the TGFβ path-
way is predicted to play an important 
tumor suppressor role in many tis-
sues (Pardali and Moustakas, 2007; 
Bierie and Moses, 2006). Surprisingly 
however, mice with targeted ablation 
of TGFβ receptors in several different 
epithelia have not developed sponta-
neous tumors in any studies done to 
date (Lu et al., 2006; Forrester et al., 
2005; Munoz et al., 2006; Ijichi et al., 
2006), suggesting that much remains 
to be understood about the function-
ing of this pathway.
New light has been shed on this 
question in a study by Elaine Fuchs 
and coworkers in the current issue 
of Cancer Cell (Guasch et al., 2007). 
All the known effects of TGFβ fun-
nel through the ligand-binding type 
II TGFβ receptor (TβRII), which the 
Fuchs group selectively inactivated 
in several stratified and glandular 
epithelia. They found that their con-
ditional knockout (CKO) mice rapidly 
developed spontaneous squamous 
cell carcinomas with high penetrance, but interestingly, these tumors arose 
only in the anogenital region and not 
at other targeted sites, such as the 
skin. Their in-depth comparison of 
the two different sites, integrated with 
analysis of the wound healing pheno-
type in the same animals, has yielded 
new insights into the role of TGFβ in 
epithelial carcinogenesis.
Early clues came from analysis of 
the balance between proliferation and 
apoptosis in asymptomatic CKO epi-
thelia. As expected, deletion of TβRII 
caused a mild increase in epithelial 
cell proliferation in both the anogeni-
tal epithelia and the skin, confirming 
that endogenous TGFβ normally pro-
vides a tonic growth inhibitory signal 
at both sites. Despite this increase in 
proliferation, in young mice normal 
homeostasis was preserved in all tis-
sues by a compensatory increase in 
apoptosis. However, in older mice, 
homeostatic mechanisms broke down 
specifically in the TβRII null anogeni-
tal epithelia, where rapid proliferation 
persisted unopposed by compensa-
tory apoptosis, and ultimately tumors 
developed.
So, what is unique about the ano-
genital region that might provoke this 
catastrophic failure of homeosta-
sis in the TβRII null epithelium? This 
region is prone to mechanical trauma 
in mice, but the authors were able to 
show that repeated wounding failed 
to induce carcinomas in the backskin Cancer Cell 12epidermis, suggesting that intermit-
tent trauma alone was not the culprit. 
Intriguingly, tumors in the anal canal 
were found to arise primarily at the 
transitional zone where the stratified 
squamous epithelium of the anal skin 
merges with the mucosal epithelium 
of the large intestine. Classic pathol-
ogy recognizes that tumors frequently 
arise in transition zones between 
different types of epithelia, and it is 
likely that cells in such zones receive 
conflicting informational cues from 
their different neighbors, leading to a 
chronic state of “identity crisis” that 
may destabilize normal differentiation 
and homeostasis programs. Indeed, 
the Fuchs group found that, even in 
wild-type mice, the epithelium of the 
transitional zone in the anus naturally 
showed many features reminiscent of 
hyperproliferative epidermis. These 
included aberrant expression of dif-
ferentiation markers, enhanced Ras-
MAPK signaling, and locally increased 
inflammation.
Could any features of this chroni-
cally destabilized state contribute to 
the spontaneous tumorigenesis at 
the anogenital site in the CKO mice? 
Ras pathway activation was an obvi-
ous suspect, and the authors showed 
that, although tumors did not form 
spontaneously in the TβRII null back-
skin, TβRII null keratinocytes express-
ing oncogenic Ha-Ras rapidly formed 
aggressively invasive and metastatic , October 2007 ©2007 Elsevier Inc. 293
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the anal tumors, tumor formation 
in the skin was associated with a 
dramatic reduction in compensa-
tory apoptosis. Most importantly, 
Ras activation in keratinocytes was 
accompanied by an enhanced sen-
sitivity to the proapoptotic effects of 
TGFβ in vitro, suggesting that TGFβ-
induced apoptosis may be critically 
important in opposing unscheduled 
increases in cell proliferation.
The data suggest a model in which 
different activities of TGFβ are called 
into play under different circum-
stances (Figure 1). Thus, TGFβ in its 
role as an antiproliferative factor is 
engaged in tonic maintenance of cell 
number in the normal epithelium, and 
loss of this particular contribution of 
TGFβ can readily be offset by com-
pensatory apoptotic mechanisms that 
are TGFβ independent. This role could 
be viewed as a “custodial” function. 
In contrast, TGFβ in its role as a pro-
apoptotic factor seems to be a crucial 
“first responder” in the face of major 
proliferative challenge. The nature of 
the challenge could be acute onco-
gene activation (e.g., mutant Ha-Ras in 294 Cancer Cell 12, October 2007 ©2007the backskin), or chronically elevated 
signaling through proto-oncogenic 
pathways (e.g., persistently elevated 
Ras/MAPK signaling in the junctional 
zone of the anal canal in older mice). 
At least in stratified epithelia stressed 
by hyperactivation of the Ras pathway, 
this role of TGFβ cannot be compen-
sated for by other pathways, and loss 
of TGFβ response permits unopposed 
proliferation.
A surfeit of cells alone does not 
make a carcinoma, so it was of interest 
to ask whether loss of TGFβ response 
destabilizes the tissue in other ways 
that might also contribute to tumor 
development. In light of the known 
parallels between tumors and wounds, 
the authors analyzed the wound heal-
ing phenotype in their mice. Wounds 
on the skin of the CKO mice healed 
faster than their wild-type counter-
parts, reflecting a migratory and inva-
sive advantage in CKO keratinocytes, 
which depended on activation of 
the Src/FAK pathway by β1-integrin. 
Interestingly, the TβRII null anal canal 
showed evidence of β1-integrin acti-
vation and elevated FAK activity even 
in the asymptomatic state. Elsevier Inc.The data suggest that another very 
important role of endogenous TGFβ 
in normal epithelia may be to limit the 
migratory and invasive potential of 
these cells. Through tonic suppres-
sion of β1 integrin activation, wild-
type cells may be rendered relatively 
“deaf” to promigratory signals ema-
nating from the stroma and elsewhere. 
In contrast, TβRII null cells are poised 
to leave the neighborhood, and their 
latent migratory phenotype can read-
ily be unmasked by oncogene activa-
tion and/or tissue disruption. Thus, 
not only is an intact TGFβ pathway 
critical for the emergency response 
to undesirable increases in cell pro-
liferation, but also the data suggest 
an important new tumor suppressor 
role for the pathway in maintaining 
“locostasis”—ensuring that cells stay 
in their proper location. Superficially, 
this result seems at variance with an 
extensive literature on TGFβ as a pro-
migration and proinvasion factor in 
tumorigenesis (Pardali and Mousta-
kas, 2007). However, other biological 
responses to TGFβ can switch radi-
cally as molecular context changes 
(Sanchez-Capelo, 2005), and the 
migratory response may simply be 
an additional example of this general 
phenomenon.
A number of interesting questions 
are raised by this work. How appli-
cable are these findings to other 
epithelia, and to other oncogenic 
insults? Are there other chronically 
destabilized epithelia that might be 
prone to spontaneous tumorigene-
sis on loss of TGFβ response? What 
is the relative importance of the pro-
apoptotic and antimigration/inva-
sion effects of TGFβ compared with 
other potential tumor suppressor 
activities, such as induction of repli-
cative senescence and maintenance 
of genomic stability? Why does loss 
of TβRII not affect proliferation or 
apoptosis of the stem cells in the 
hair follicle bulge region, despite 
evidence for TGFβ pathway activity 
in this compartment? Much remains 
to be learned, but the Fuchs article 
clearly demonstrates that loss of 
TGFβ response can destabilize tis-
sue homeostasis at multiple levels, 
leading to a tumor-prone state.
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partment in the tumor? Determinants 
of tumor phenotype and relationship 
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correlate with tumor behavior? Are 
tumors that express more markers 
of differentiation less aggressive? As 
well, the relationship of tumor behav-
ior to the putative cell of origin is not 
understood. Do tumors arise in a 
stem cell or a more differentiated cell 
compartment, and does the behavior 
and phenotype of the tumor depend 
on the cell compartment of origin? 
Are tumors that arise in stem cell 
compartments more malignant than 
those arising in progenitors, or vice 
versa? These questions come in to 
focus in the study by Bruggeman and 
colleagues (Bruggeman et al., 2007).
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Bmi1 has been implicated in con-
trol of stem cells in multiple tissues, 
particularly as a positive regulator of 
self renewal, and Bmi1-deficient mice 
have deficiencies in their stem cell 
compartments, including the brain 
(Molofsky et al., 2003; Park et al., 
2003). Bmi1 promotion of proliferation 
and self renewal is thought to relate 
to suppression of the Ink4a/Arf locus 
(Bruggeman et al., 2005), although 
other loci have recently been shown 
to be targeted as well (Fasano et al., 
2007). Ink4a/Arf loss itself, consistent 
with its tumor suppressor role, causes 
increased neural stem cell activity in 
vivo (Molofsky et al., 2006). Although 
Ink4a/Arf is lost genetically in a large 
fraction of human glioblastoma sam-
ples, mice deficient for Ink4a/Arf rarely 
develop spontaneous brain tumors.
The current study by Bruggeman 
et al. (2007) attempts to further probe 
the functional role of Bmi1 together 
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